Therapeutic Asset Ratings
160 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Thiotepa
Multiple Sclerosis, Secondary Progressive
Stanford University
P1
CC
(43)
Treg Cells
Allogeneic Hematopoietic Cell Transplantation (HCT)
Stanford University
P1
CC
(43)
FTC-146
Chronic Pain Syndrome
Stanford University
P1
CC
(42)
FTC-146
Neuralgia
Stanford University
P1
CC
(42)
b7-h3cart
Neuroblastoma
Stanford University
P1
CC
(41)
b7-h3cart
Osteosarcoma
Stanford University
P1
CC
(41)
cd22 car-t
Burkitt Lymphoma
Stanford University
P1
CC
(41)
cd22 car-t
Lymphoplasmacytic Lymphoma
Stanford University
P1
CC
(41)
cd22 car-t
Waldenstrom Macroglobulinemia
Stanford University
P1
CC
(41)
cd4+cd25+ regulatory t cells
Chronic Myelogenous Leukemia
Stanford University
P1
CC
(41)
Niclosamide
Acute Myeloid Leukemia
Stanford University
P1
CC
(41)
PROPOFOL
Healthy Volunteers
Stanford University
P1
CC
(41)
ARA-GUANOSINE
Non-Hodgkin's Lymphoma
Stanford University
P1
C
(39)
b7-h3cart
Sarcoma
Stanford University
P1
C
(39)
cd22 car-t
Large B-Cell Lymphoma
Stanford University
P1
C
(39)
cd22 car-t
Marginal Zone Lymphoma
Stanford University
P1
C
(39)
cd4+cd25+ regulatory t cells
Acute Leukemia
Stanford University
P1
C
(39)
Nktr-255
B-Cell Acute Lymphoblastic Leukemia
Stanford University
P1
C
(39)
Nktr-255
Minimal Residual Disease
Stanford University
P1
C
(39)
Plerixafor
Acute Leukemia
Stanford University
P1
C
(39)
Rosuvastatin
Inflammatory Bowel Disease
Stanford University
Early P1
C
(39)
Rosuvastatin
Primary Sclerosing Cholangitis
Stanford University
Early P1
C
(38)
Topamax
Pain, Postoperative
Stanford University
Early P1
C
(38)
cd22 car-t
Follicular Lymphoma
Stanford University
P1
C
(37)
cd22 car-t
Leukemia
Stanford University
P1
C
(37)
Showing 126 to 150 of 160 assets
Previous
Page 6 of 7
Next
